Marc van Dijk
2022
In 2022, Marc van Dijk earned a total compensation of $651.2K as Chief Scientific Officer at MiNK Therapeutics.
Compensation breakdown
| Bonus | $79,853 |
|---|---|
| Option Awards | $281,250 |
| Salary | $252,334 |
| Other | $37,737 |
| Total | $651,174 |
van Dijk received $281.3K in option awards, accounting for 43% of the total pay in 2022.
van Dijk also received $79.9K in bonus, $252.3K in salary and $37.7K in other compensation.
Rankings
In 2022, Marc van Dijk's compensation ranked 3,897th out of 5,676 executives tracked by ExecPay. In other words, van Dijk earned more than 31.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,897 out of 5,676 | 31st |
Division Manufacturing | 2,203 out of 3,084 | 29th |
Major group Chemicals And Allied Products | 1,068 out of 1,399 | 24th |
Industry group Drugs | 1,002 out of 1,300 | 23rd |
Industry Biological Products, Except Diagnostic Substances | 236 out of 295 | 20th |
Source: SEC filing on April 29, 2024.
van Dijk's colleagues
We found two more compensation records of executives who worked with Marc van Dijk at MiNK Therapeutics in 2022.